This study will explore the hypothesis that hyperactivation of the cAMP response element-binding protein (CREB)-a transcription factor with diverse functions in the central nervous system and metabolic regulation-contributes to mitochondrial defects and pathologic reactive oxygen species (ROS) formation in ataxia-telangiectasia (A-T), a neurodegenerative disease caused by mutations in the ATM gene. ATM encodes a protein kinase with instrumental roles in the signaling and repair of DNA double-strand breaks, a highly carcinogenic form of DNA damage. ATM is also thought to play an important role in mitochondrial homeostasis and suppression of toxic ROS; however this aspect of ATM function is poorly understood. In published work we showed that ATM phosphorylates CREB on a conserved cluster of Ser residues that attenuates CREB transactivation potential in response to DNA damage and other forms of cellular stress. Of importance to this proposal, an independent study recently showed that the nuclear corepressor NCoR1 represses a large number of CREB target genes with mitochondrial function. Here we will explore the idea that ATM, CREB, and NCoR1 function in a common pathway to critically attenuate mitochondrial function and ROS generation in response to DNA damage and oxidative stress. Specifically, we propose that ATM-mediated phosphorylation of CREB recruits NCoR1 to silence mitochondrial target genes. The relevance of this hypothesis for A-T is that defective CREB phosphorylation may engender mitochondrial defects and oxidative stress that contribute to neuronal injury. We will test these ideas using a combination of biochemical and genetic approaches, including the use of gene-targeted mice expressing a mutant CREB allele (CREBS111A) refractory to phosphorylation by ATM. CREBS111A mice exhibit metabolic abnormalities and alterations in CREB- mediated gene expression, and fibroblasts and neurons from these mice will be used to explore the mechanisms of NCoR1-dependent CREB attenuation. In summary, the proposed work will define the impact of ATM-mediated CREB phosphorylation on transcriptional regulation and mitochondrial homeostasis. Results from this work may provide important new insights into how loss of ATM leads pathologic oxidative stress in A-T.
The Specific Aims of the proposal are to: i) Assess ROS, mitochondrial dynamics, and cerebellar gene expression in CREBS111A mice; and ii) Define signal and phosphorylation-dependent functional relationships between CREB and NCoR1.

Public Health Relevance

The goal of this work is to better understand the causes of neurodegeneration in ataxia-telangiectasia (A-T) a rare genetic disease caused by mutations in the ataxia-telangiectasia-mutated (ATM) gene. We have identified an ATM-regulated pathway impacting the CREB transcription factor that putatively regulates mitochondria, the key energy-producing structures in all mammalian cells. We propose that ATM mutations lead to hyperactivation of CREB and mitochondrial damage, which critically contributes to neurodegeneration in A-T.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS090313-01A1
Application #
8970492
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Gwinn, Katrina
Project Start
2015-07-15
Project End
2017-06-30
Budget Start
2015-07-15
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Kim, Sang Hwa; Stiles, Shannon G; Feichtmeier, Joseph M et al. (2018) Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated ALS. Hum Mol Genet 27:322-337